Search Results

You are looking at 1 - 1 of 1 items for :

  • Author: Tian Zhou x
Clear All Modify Search
Tian Zhou School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China
Department of Breast Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

Search for other papers by Tian Zhou in
Google Scholar
PubMed
Close
,
Dai-wei Zhao School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China
Department of Surgery, Second People's Hospital of Guizhou Province, Guiyang, Guizhou, China

Search for other papers by Dai-wei Zhao in
Google Scholar
PubMed
Close
,
Ning Ma School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China

Search for other papers by Ning Ma in
Google Scholar
PubMed
Close
,
Xue-ying Zhu School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China

Search for other papers by Xue-ying Zhu in
Google Scholar
PubMed
Close
,
Xing-hong Chen Department of Surgery, Second People's Hospital of Guizhou Province, Guiyang, Guizhou, China

Search for other papers by Xing-hong Chen in
Google Scholar
PubMed
Close
,
Xue Luo Department of Breast Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

Search for other papers by Xue Luo in
Google Scholar
PubMed
Close
,
Song Chen School of Clinical Medicine, GuiZhou Medical University, Guiyang, Guizhou, China

Search for other papers by Song Chen in
Google Scholar
PubMed
Close
, and
Qing-jun Gao Department of Thyroid Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

Search for other papers by Qing-jun Gao in
Google Scholar
PubMed
Close

Objective

Thyroid cancer (THCA) is the most common endocrine cancer in the world. Although most patients with THCA have a good prognosis, the prognosis of those with THCA who have an extra-glandular invasion, vascular invasion, and distant metastasis is poor. Therefore, it is very important to find potential biomarkers that can effectively predict the prognosis and progression of highly aggressive THCAs. It has been identified that forkhead box P4 (FOXP4) may be a new biomarker for the proliferation and prognosis for tumor diagnosis. However, the expression and function of FOXP4 in THCA remain to be determined.

Methods

In the present study, the function of FOXP4 in cells was investigated through the comprehensive analysis of data in The Cancer Genome Atlas and combined with experiments including immunohistochemistry (IHC), colony formation, Cell Counting Kit-8 assay, wound scratch healing, and transwell invasion assay.

Results

In the present study, relevant bioinformatic data showed that FOXP4 was highly expressed in THCA, which was consistent with the results of the IHC and cell experiments. Meanwhile, 10 FOXP4-related hub genes were identified as potential diagnostic genes for THCA. It was found in further experiments that FOXP4 was located in the nucleus of THCA cells, and the expression of FOXP4 in the nucleus was higher than that in the cytoplasm. FOXP4 knockdown inhibited in vitro proliferation of the THCA cells, whereas overexpression promoted the proliferation and migration of THCA cells. Furthermore, deficiency of FOXP4 induced cell-cycle arrest.

Conclusion

FOXP4 might be a potential target for diagnosing and treating THCA.

Open access